Patients and methods: Retrospective describe method, 45 mutated EGFR Non-small cell lung cancer patients, stage IIIb or IV get first-line treatment with TKIs (Erlotinib or Gefitinib) at Huu Nghi Hospital from 6/2015 to 9/2022.